Cellular Goods shares: should I buy for my portfolio?

Cellular Goods shares listed on the London Stock Exchange last week via an IPO. Here, Edward Sheldon looks at the investment case.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

One UK stock that’s hot right now is Cellular Goods (LSE: CBX), which listed on the London Stock Exchange last week. Yesterday, CBX was the third-most viewed stock on Hargreaves Lansdown’s investment platform.

Is this a growth stock I should consider for my own investment portfolio? Let’s take a look at the investment case.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

Cellular Goods: what’s all the fuss about?

Cellular Goods is an innovative company that’s developing skincare and athletic recovery products formulated with engineered cannabinoids. The company – which currently has a market-cap of around £65bn – is partly owned (5%) by global celebrity David Beckham through DB Ventures.

Cellular Goods’ USP is its products are lab-made. This means that every batch is identical and free from pesticides, contaminants, and impurities. The company plans to sell its products direct to consumers via its website and through partnerships with retailers. It says its supply-chain is ‘clean, green, short, and traceable’.

CBX is led by CEO Alexis Abraham who has experience in strategic branding, communications, and internet-enabled businesses. Meanwhile, its head of Research & Product Development is Alexia Blake, who is a pioneer in the North American cannabis industry with a proven track record of developing top products. She previously worked at MedReleaf Corp. MedReleaf was one of the first Canadian producers of medical cannabis to receive a license from Health Canada. Peter Wall, who is the CEO of Argo Blockchain, is chairman.

I’m bullish on cannabis

In a recent article on Kanabo Group, I explained that I’m quite bullish on the prospects for the legal cannabis industry as a whole. Cannabis isn’t a cure, but is being touted as having some impact — however small — when treating a wide range of conditions. These conditions include Alzheimer’s, Parkinson’s, arthritis, chronic pain, epilepsy, anxiety, and depression. Between now and 2026, the global legal cannabis market is projected to grow at an annualised rate of more than 30%. This means there should be plenty of opportunity for astute investors.

Having said that, I have reservations about investing in Cellular Goods shares. For starters, the company hasn’t sold any products yet. This means its products are unproven. It also means there’s no revenue at present. This adds a lot of risk to the investment case, in my view, as we simply have no idea how high sales will be. So, determining the right valuation for the company isn’t easy. 

Another issue is that it’s hard, at this stage, to determine if the company has a genuine competitive advantage. Having done some research, I think it’s likely that, in the years ahead, we’ll see more lab-based cannabis products come to the market.

CBX shares: should I buy?

Weighing everything up, Cellular Goods shares are too risky for me right now. The company certainly looks to have growth potential. However, there are many unknowns.

All things considered, I think there are other, safer growth stocks I could buy right now that are a better fit for my portfolio.

Like this one...

FREE REPORT: Why this £5 stock could be set to surge

Are you on the lookout for UK growth stocks?

If so, get this FREE no-strings report now.

While it’s available: you'll discover what we think is a top growth stock for the decade ahead.

And the performance of this company really is stunning.

In 2019, it returned £150million to shareholders through buybacks and dividends.

We believe its financial position is about as solid as anything we’ve seen.

  • Since 2016, annual revenues increased 31%
  • In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259
  • Operating cash flow is up 47%. (Even its operating margins are rising every year!)

Quite simply, we believe it’s a fantastic Foolish growth pick.

What’s more, it deserves your attention today.

So please don’t wait another moment.

Get the full details on this £5 stock now – while your report is free.

Edward Sheldon owns shares in Hargreaves Lansdown. The Motley Fool UK has recommended Hargreaves Lansdown. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A beach at sunset where there is an inscription on the sand "Breathe Deeeply".
Investing Articles

Stock market crash: here’s why falling prices is good news

Over in the US, a stock market crash is battering high-priced stocks. But I see falling shares as an opportunity…

Read more »

Hand flipping wooden cubes for change wording" Panic " to " Calm".
Investing Articles

These 5 FTSE 100 shares crashed in 2022. I’d buy 1 today

Although the FTSE 100 index is flat in 2022, some Footsie shares have crashed hard this year. But I see…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How investors can boost their passive income when the FTSE is falling

Stock markets are plagued with fears right now. Here's why I firmly believe those fears improve our passive income prospects.

Read more »

Image of person checking their shares portfolio on mobile phone and computer
Investing Articles

2 cheap UK shares to buy right now!

Recent market volatility means many top stocks now trade at rock-bottom prices. Here are two cheap UK shares I'm thinking…

Read more »

Rolls-Royce's business aviation engine, the Pearl 700
Investing Articles

The Rolls-Royce share price is just pennies. Am I missing something?

As the Rolls-Royce share price lingers in penny stock territory, our writer revisits the investment case that has attracted him…

Read more »

Compass pointing towards 'best price'
Investing Articles

How to put a valuation on the Woodbois share price

The Woodbois share price has fallen from its recent spike, so should I buy now? And how can I work…

Read more »

Inflation in newspapers
Investing Articles

I’d fight inflation with these 2 FTSE 100 dividend shares

With inflation hitting a 9%, I'm boosting my passive income and turning to these two FTSE 100 dividend stocks.

Read more »

New Ways of Investing - Hands Only Using Smart Phone
Investing Articles

2 cheap Footsie stocks to buy for BIG dividends!

The recent stock market sell-off leaves plenty of top stocks looking too cheap to miss. Here are two great Footsie…

Read more »